SUC2C Grant Could Facilitate Development of Novel Therapies in Gastroesophageal Cancer

A new collaboration between Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center to enhance gastroesophageal cancer care in patients who do not respond to standard treatment has received a 3-year grant from Stand Up To Cancer (SU2C).